BLOG POST
Traditional HCP marketing often fails to align with real-world clinical decision windows. Phreesia’s ProviderConnect aligns life sciences messaging to real patient appointments and near-term clinical moments, with a privacy-first approach that helps brands engage clinicians when it matters most.
As a clinician, keeping up with medical advances and applying new information in real time during increasingly short visits is incredibly challenging.
During the workday, our clinical decision making is driven by tools that help us move quickly and safely. We react to questions that arise in the moment, which might mean checking UpToDate for the latest evidence-based recommendations, using OpenEvidence to sanity-check a question that comes up mid-visit or referencing updated organizational protocols when a workflow changes. As a hospitalist, I often jumped between checking anticoagulation dosing for a new pulmonary embolism, confirming an antibiotic regimen for a drug-resistant pneumonia or making sure a heart failure plan reflects current standards.
Then, in the more quiet professional moments, we try to fill in our knowledge gaps. Our ability to recognize less-familiar conditions, understand where new or evolving therapies fit into practice and weigh how they compare to existing options depends on that discovery time. We skim email digests from publications like JAMA or NEJM and click through to full articles that are relevant to our practice or pique our interest. We attend conferences. We compare notes with our colleagues to discuss less-common presentations or new therapies that might help the next patient we care for.
Not surprisingly, those off-clinic moments also include being marketed to.
Sometimes the information we see feels relevant. Often times, it reflects what we needed a while ago, not what we will need next.
The challenge: Marketing doesn’t time up well with real-world care and upcoming clinical needs
In medicine, timing is not a marketing preference. It can determine whether a condition is diagnosed earlier, whether therapy is intensified before complications occur or whether a patient experiences preventable delays. When these windows are missed, they may be missed for months or longer, until the HCP sees the patient again.
Consider a few examples:
- Rare diseases: When HCP awareness of a condition is low, the critical moment is rarely prescribing. It‘s pattern recognition and diagnostic suspicion across the range of clinicians a patient with a rare disease may see before receiving the correct diagnosis. Education delivered too early is easy to forget and hard to apply. Education delivered too late can contribute to delayed recognition, with potential downstream consequences for patients.
- Progressive chronic disease: Many chronic conditions follow a predictable arc. There is often a window when intensifying therapy can prevent irreversible damage, hospitalization or long-term complications. If that window is missed, the conversation shifts from prevention to intervention. Education that surfaces when a patient is approaching a treatment threshold may support more informed and timely clinical decision making.
- Therapies with complex access: For many advanced therapies, identifying the right patient is only the first step. Eligibility criteria, baseline testing, prior authorization documentation and specialty pharmacy coordination can delay treatment if the care team is not prepared. When clinicians approach the visit with those requirements in mind, they can order the right tests, document appropriately and initiate access steps sooner, shortening time to therapy.
- New guidelines and new indications: Adoption of new guidelines or therapies takes time. What changes practice is not a single impression. It is credible information that builds trust and arrives when the clinician is managing a patient who could benefit.
In each of these cases, awareness alone is not enough. Proximity of that awareness to a real clinical decision is what gives information its power.
Yet historically, much of HCP engagement has been optimized for consistency of presence rather than alignment with decision windows. The assumption has been that reach and repetition build familiarity, and that familiarity influences prescribing behavior.
However, clinicians operate in constant triage, managing immediate clinical risk, taking care of documentation and administrative burdens, and coordinating across teams and settings. Information that does not connect to the patient in front of us—or the patient we’re about to see—is therefore deprioritized.
Over time, repetition without context becomes background noise. Even strong, clinically sound content can lose impact if it consistently arrives outside the moments when it can influence care.
The solution: Elevate clinical timing from a variable to a strategy
Arguably, the most meaningful shift HCP marketing can make is to treat timing as a primary driver of relevance rather than a secondary consideration—an idea which finally, thanks to advances in AI, is starting to become a reality. This does not require marketers to abandon lists or throw out their playbook. It just requires viewing through a lens of how HCPs really work. It means moving from presence to preparedness.
Presence asks: “Have we been visible enough?”
Preparedness asks: “Are we showing up when a clinical decision is approaching?”
It feels different when information surfaces in proximity to a patient encounter. It feels supportive rather than interruptive and aligns with active thinking rather than competing for attention. And importantly, it’s possible to still keep privacy at the center while delivering information with patient-level relevance.
In practical terms, elevating timing can mean:
- Delivering diagnostic education when clinicians are about to see patients with relevant symptom profiles
- Surfacing therapy differentiation as patients approach intensification thresholds
- Equipping care teams with access and reimbursement information before prescribing decisions are finalized
- Reinforcing new clinical data when clinicians are actively managing eligible patients
The same message delivered at two different times can have dramatically different effects. Outside a decision window, it may be ignored. Within one, it may meaningfully shape care.
The opportunity: Less noise, greater impact and more meaningful engagement
When engagement aligns with real clinical moments, the experience improves for both clinicians and brands. For clinicians, the benefits are immediate:
- Reduced cognitive noise
- Greater perceived relevance
- Information that supports decisions rather than distracts from them
When messaging feels connected to real patient care, trust strengthens. Engagement feels intentional and respectful of workflow. For brands, the upside is not subtle:
- Brand interactions feel purposeful rather than promotional, strengthening long-term credibility with clinicians
- Engagement shifts from volume-driven impressions to moments that influence real-world decisions
- Investment becomes more efficient as impact is measured by clinical alignment, not just reach
- Commercial growth is fueled by sustained trust and consistency, not intermittent exposure
In recent market research among HCP marketers, 67% of respondents reported they are not currently using any solution to reach HCPs based on recent or upcoming appointments. That statistic underscores the opportunity. Much of the industry still invests heavily in backward-looking exposure while clinical care operates in forward-moving decision windows.
When timing becomes central, marketing becomes more aligned with how medicine is actually practiced. When that happens, engagement becomes less disruptive, more valuable and ultimately more supportive of patient care.
Learn more about how Phreesia’s ProviderConnect aligns life sciences messaging to real patient appointments and near-term clinical moments, with a privacy-first approach that helps brands engage clinicians when it matters most. Read Phreesia’s ProviderConnect press release.
Alicia Cowley, MD, MBA, is an internist and Medical Director at Phreesia.
